Yayıncı "Future Medicine Ltd" Scopus İndeksli Yayınlar Koleksiyonu için listeleme
Toplam kayıt 1, listelenen: 1-1
-
Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer
(Future Medicine Ltd, 2017)Aim: In this study, we aimed to therapeutically target eukaryotic elongation factor 2 kinase (eEF-2K) in an in vivo triple-negative breast cancer (TNBC) tumor model. Materials & methods: We synthesized a highly monodisperse ...